News

Norgine Welcomes TGA Registration In Australia Of IFINWIL® (Eflornithine) For Adults And Children Diagnosed With High-Risk Neuroblastoma (HRNB)[1]
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...